Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Portal Vein Occlusion”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Not applicableStudy completedNCT04168788
What this trial is testing

Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL

Who this might be right for
Hepatic Veno-Occlusive DiseaseNephroblastomaAcute Lymphoblastic Leukemia
University Hospital, Angers 85
Testing effectiveness (Phase 2)Looking for participantsNCT05987124
What this trial is testing

Defibrotide Dose-escalation for SOS Post-HSCT

Who this might be right for
Sinusoidal Obstruction SyndromeVeno-occlusive Disease
New York Medical College 20
Large-scale testing (Phase 3)Study completedNCT00272948
What this trial is testing

Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide

Who this might be right for
Hepatic Veno-Occlusive Disease
European Society for Blood and Marrow Transplantation 360
Not applicableStudy completedNCT03132337
What this trial is testing

Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study

Who this might be right for
Sinusoidal Obstruction Syndrome
Indiana University 80
Post-approval studies (Phase 4)WithdrawnNCT03963999
What this trial is testing

Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients

Who this might be right for
Sinusoidal Obstruction SyndromeVeno Occlusive Disease, HepaticBone Marrow Transplant Complications+1 more
Children's Mercy Hospital Kansas City
Not applicableUnknownNCT00563498
What this trial is testing

Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients

Who this might be right for
Pulmonary Veno-Occlusive DiseaseHepatic Veno-Occlusive DiseaseMucositis
Hospital Authority, Hong Kong 40
Not applicableStudy completedNCT05894408
What this trial is testing

Portal Vein Occlusion is a Valuable Predictor for Postoperative Nausea and Vomiting

Who this might be right for
Postoperative Nausea and Vomiting
Shanghai Zhongshan Hospital 380
Early research (Phase 1)WithdrawnNCT00062543
What this trial is testing

Hepatic Artery Infusion of CD34+ Cells

Who this might be right for
Stem Cell TransplantationLiver Diseases
M.D. Anderson Cancer Center
Not applicableNot Yet RecruitingNCT07108023
What this trial is testing

Hematological Disorders in EHPVO Patients

Who this might be right for
Extrahepatic Portal Vein Obstruction (EHPVO)ThrombophiliaMyeloproliferative Neoplasms (MPN)+5 more
Rahab Nady 115
Large-scale testing (Phase 3)Study completedNCT00358501
What this trial is testing

Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients

Who this might be right for
Severe Hepatic Veno-Occlusive Disease
Jazz Pharmaceuticals 134
Testing effectiveness (Phase 2)Ended earlyNCT01775267
What this trial is testing

ALLPS VERSUS PVO Randomized Controlled Trial

Who this might be right for
Liver Tumors Not Resectable in One Surgical Procedure
University of Zurich 7
Testing effectiveness (Phase 2)Study completedNCT00003966
What this trial is testing

Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation

Who this might be right for
Veno-occlusive Disease
Dana-Farber Cancer Institute 151
Not applicableStudy completedNCT00885950
What this trial is testing

Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants

Who this might be right for
Sinusoidal Obstruction SyndromeColorectal Liver Metastases
Maastricht University Medical Center 80
Testing effectiveness (Phase 2)UnknownNCT01886248
What this trial is testing

Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation

Who this might be right for
Hepatic Veno-Occlusive Disease
Seoul National University Hospital 32
Not applicableUnknownNCT05123326
What this trial is testing

Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome

Who this might be right for
Hepatic Vein ThrombosesHepatic Venous Outflow ObstructionPortal Vein Thrombosis+7 more
Post Graduate Institute of Medical Education and Research, Chandigarh 300
Not applicableStudy completedNCT04141735
What this trial is testing

Detection of Sinusoidal Obstruction Syndrome With Ultrasound After Allogeneic HSCT

Who this might be right for
Sinusoidal Obstruction Syndrome
Central Hospital, Nancy, France 114
Testing effectiveness (Phase 2)UnknownNCT04712435
What this trial is testing

Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation

Who this might be right for
Sinusoidal Obstruction Syndrome (SOS)Hematopoietic Stem Cell Transplant (HSCT)
Instituto Brasileiro de Controle do Cancer 80
Not applicableStudy completedNCT02483481
What this trial is testing

Using Ultrasound Elastography to Predict Development of SOS

Who this might be right for
Sinusoidal Obstruction SyndromeComplications of Bone Marrow Transplant
Children's Mercy Hospital Kansas City 45
Large-scale testing (Phase 3)Study completedNCT00820339
What this trial is testing

Pringle's Maneuver Versus Selective Hepatic Vascular Exclusion in Hepatectomy

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 132
Not applicableLooking for participantsNCT06715046
What this trial is testing

Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
GVHD - Graft-Versus-Host DiseaseInfections After HSCTTransplant Associated Microangiopathy TAM+2 more
University of Turin, Italy 30
Next Page